|
|
Post by notamnkdmillionaire on Aug 11, 2015 19:00:54 GMT -5
<--- What do you think, Liane? What isn't known is that the momma giraffe was the first to try that inhaled oxytocin after she gave birth. Looks like it works like a charm! |
|
|
|
Post by pktrump on Aug 11, 2015 20:35:39 GMT -5
I work in a medical setting (i.e hospital). Have seen a noticeable increase in atypical TB pneumonia over the years, which is more common in many of the migrant workers flooding into the US. The disease is transmissible and very resistant to standard oral TB antibiotics. There are a myriad of other infectious and neoplastic lung diseases that need new approaches which begin or involve the alveoli where Technosphere is absorbed. Have thought that by now we would have heard definitive and detailed potential applications for the Techno platform that were being researched, particularly in regards to pulmonary disease where a new direction in therapy is desperately needed. I have upmost respect for Matt and Al: I sense, or should I say my perception is, they are leery to provide us with much more than plain vanilla CCs in an attempt to avoid the perception of over promising and under delivering. Maybe like many in the medical profession, hospitals, and corps, they are fearful of litigation: the Trial Lawyers and the litigation industry IMO are the most powerful, out of control and corrupted industries in our country, even more so that Wall Street. This is not the case in Europe or anywhere else for that matter. While SNY may want to keep a tight lid on what potential applications there are for competitive reasons, I think avoidance of litigation is of equal importance in directing their public demeanor and disclosures if you will. MNKD has adjusted there public approach, as so many other companies have, of increasing obscurity and reluctance to distribute a clear vision and the potentials of Techno. Regarding AFZ, this is why MNKD welcomed the black box warning; they don't want smokers using, ever, to avoid even association with malignancies. This kind of litigation fear is rampant in the medical profession; I also wonder if this same fear is affecting the scripts as MDs want to see it working in others for a certain period of time, then seeing the major leaders in the space endorse, before prescribing. Just a thought.  |
|
|
|
Post by longstocking on Aug 11, 2015 21:13:54 GMT -5
I work in a medical setting (i.e hospital). Have seen a noticeable increase in atypical TB pneumonia over the years, which is more common in many of the migrant workers flooding into the US. The disease is transmissible and very resistant to standard oral TB antibiotics. There are a myriad of other infectious and neoplastic lung diseases that need new approaches which begin or involve the alveoli where Technosphere is absorbed. Have thought that by now we would have heard definitive and detailed potential applications for the Techno platform that were being researched, particularly in regards to pulmonary disease where a new direction in therapy is desperately needed. I have upmost respect for Matt and Al: I sense, or should I say my perception is, they are leery to provide us with much more than plain vanilla CCs in an attempt to avoid the perception of over promising and under delivering. Maybe like many in the medical profession, hospitals, and corps, they are fearful of litigation: the Trial Lawyers and the litigation industry IMO are the most powerful, out of control and corrupted industries in our country, even more so that Wall Street. This is not the case in Europe or anywhere else for that matter. While SNY may want to keep a tight lid on what potential applications there are for competitive reasons, I think avoidance of litigation is of equal importance in directing their public demeanor and disclosures if you will. MNKD has adjusted there public approach, as so many other companies have, of increasing obscurity and reluctance to distribute a clear vision and the potentials of Techno. Regarding AFZ, this is why MNKD welcomed the black box warning; they don't want smokers using, ever, to avoid even association with malignancies. This kind of litigation fear is rampant in the medical profession; I also wonder if this same fear is affecting the scripts as MDs want to see it working in others for a certain period of time, then seeing the major leaders in the space endorse, before prescribing. Just a thought. Well said. I think this is a big reason why we get "vanilla" information. Potential litigation is a very real issue. Even in my profession (local government), EVERY piece of correspondence is written with "how would a judge respond to this?" as the final reviewing thought. Better to remain silent than shoot off at the mouth with bright ideas that could get you sued. |
|
|
|
Post by babaoriley on Aug 11, 2015 21:45:39 GMT -5
"they are fearful of litigation: the Trial Lawyers and the litigation industry IMO are the most powerful, out of control and corrupted industries in our country, even more so that Wall Street." pk, as much as I dislike most lawyers who file securities class action suits, in my opinion, as a group, they have nowhere near the power and influence of the Wall Street crowd. And so many are the hired guns of the Wall Street crowd, well, c'mon, for $1,200/hr, who knows what a guy might do!  Having said that, MNKD's been bitten by lawyers before, so no doubt they are extra wary. |
|
|
|
Post by mnholdem on Aug 12, 2015 7:20:17 GMT -5
Please don't ask me to provide a link or know the exact conference it was stated, but didn't Matt mention within the past year that it's pretty simple for an investor to see what MannKind is up to by keeping track of their patent applications? I posted within the past few weeks that some BP and/or their subsidiary companies have inhalable technologies. If they think that MannKind is in the process of developing a generic drug that could harm their market share, all they need to do is to develop their own inhalable and then threaten to sue MannKind to stop any further development.
For that reason (and Matt mentioned this at a conference within the past few months) MannKind will not be divulging the various API slated for Technosphere UNTIL the benefits of being delivered as inhalable drugs have been sufficiently patent-protected.
Lawyers, competitors, Wall Street wolves... it's a jungle out there, n'est pas?
|
|
|
|
Post by papihoyos on Aug 12, 2015 7:23:10 GMT -5
Please don't ask me to provide a link or know the exact conference it was stated, but didn't Matt mention within the past year that it's pretty simple for an investor to see what MannKind is up to by keeping track of their patent applications? I posted within the past few weeks that some BP and/or their subsidiary companies have inhalable technologies. If they think that MannKind is in the process of developing a generic drug that could harm their market share, all they need to do is to develop their own inhalable and then threaten to sue MannKind to stop any further development. For that reason (and Matt mentioned this at a conference within the past few months) MannKind will not be divulging the various API slated for Technosphere UNTIL they have been sufficiently patent-protected. Lawyers, competitors, Wall Street wolves... it's a jungle out there, n'est pas? Don't you think they already know? "Three may keep a secret if two are dead" Ben Franklin |
|
|
|
Post by peppy on Aug 12, 2015 7:27:49 GMT -5
I posted within the past few weeks that some BP and/or their subsidiary companies have inhalable technologies. If they think that MannKind is in the process of developing a generic drug that could harm their market share, all they need to do is to develop their own inhalable and then threaten to sue MannKind to stop any further development. For that reason (and Matt mentioned this at a conference within the past few months) MannKind will not be divulging the various API slated for Technosphere UNTIL the benefits of being delivered as inhalable drugs have been sufficiently patent-protected. Lawyers, competitors, Wall Street wolves... it's a jungle out there, n'est pas? I remember reading the post... naming the BP proceeding with inhalable technology?
|
|
|
|
Post by pktrump on Aug 12, 2015 19:37:28 GMT -5
 It is a jungle and a battle zone out there; maybe I've been watching too many WWII documentaries and I'm worried the French are going to get flanked by a panzer unit. I think SNY is being too cautious and timid; they need to bring in support from major ENdos stat and direct that enthusiasm into DTC via social media and major networks: SNY should be way more aggressive with AFZ than they currently are. While the fantastic results we have witnessed on social media are small in number, those results are highly likely reproducible in millions. Timing is everything. SNY should absolutely demonstrate their confidence in AFZ. I dont like riding Shetland ponies into battle. Quit with the slow French stuff, this is the US.
|
|
|
|
Post by prosper on Aug 13, 2015 6:17:36 GMT -5
Liane
While i am not knowledgeable enough to do the analysis, perhaps you could start a new thread meant to analyze the patents in more layman's terms? I know there are several on the board with enough technical awareness to comment in a synopsis form as to the practical application potentials of patents.
|
|
|
|
Post by liane on Aug 13, 2015 6:46:30 GMT -5
prosper,
Anyone can start a thread. I'll leave it to the board - if someone wants to initiate that.
|
|
|
|
Post by mnholdem on Aug 13, 2015 8:52:28 GMT -5
It is a jungle and a battle zone out there; maybe I've been watching too many WWII documentaries and I'm worried the French are going to get flanked by a panzer unit. I think SNY is being too cautious and timid; they need to bring in support from major ENdos stat and direct that enthusiasm into DTC via social media and major networks: SNY should be way more aggressive with AFZ than they currently are. While the fantastic results we have witnessed on social media are small in number, those results are highly likely reproducible in millions. Timing is everything. SNY should absolutely demonstrate their confidence in AFZ. I dont like riding Shetland ponies into battle. Quit with the slow French stuff, this is the US. Oh no, don't make me post my Fleetwood Mac Shetland-pony-gets-butchered video again |
|
|
|
Post by tayl5 on Aug 13, 2015 13:14:05 GMT -5
In addition to its gynecological effects, oxytocin has been implicated in a broad range of psychosocial responses, most of which involve positive feelings toward others and increased social bonding. Maybe if longs and shorts got priority access to inhaled oxytocin as a perk for being associated with this company, we might chill out and "all just get along".
|
|
|
|
Post by longstocking on Aug 13, 2015 13:20:49 GMT -5
In addition to its gynecological effects, oxytocin has been implicated in a broad range of psychosocial responses, most of which involve positive feelings toward others and increased social bonding. Maybe if longs and shorts got priority access to inhaled oxytocin as a perk for being associated with this company, we might chill out and "all just get along". Sounds like you've been visiting YMB and Stock Twits too much. Things are pretty peaceful and informative here on ProBoards. |
|
|
|
Post by tayl5 on Aug 13, 2015 15:10:58 GMT -5
I agree Proboards is an oasis of calm in the storm. I was thinking more of the turmoil outside.
I appreciate everyone's efforts to keep it that way.
|
|
|
|
Post by jay1ajay1a on Aug 13, 2015 18:27:07 GMT -5
We try to keep it nice in here. If not there are very powerful folks who will lock down the post.
I like it here much better and don't spend much time on the other boards at all.
|
|
